Relx (RELX) EBT (2021 - 2025)
On a quarterly basis, EBT rose 5.52% to $7442.3 in Q4 2025 year-over-year; TTM through Dec 2025 was $7442.3, a 5.52% increase, with the full-year FY2025 number at $3.7 billion, up 11.46% from a year prior.
Relx (RELX) has 4 years of EBT data on record, last reported at $7442.3 in Q4 2025.
- EBT reached $7442.3 in Q4 2025 per RELX's latest filing, up from $7052.8 in the prior quarter.
- Over the last five years, EBT for RELX hit a ceiling of $2.6 billion in Q4 2022 and a floor of $7052.8 in Q4 2024.
- A 4-year average of $1.3 billion and a median of $1.2 billion in 2021 define the central range for EBT.
- Peak YoY movement for EBT: rose 5.65% in 2022, then increased 5.52% in 2025.
- Tracing RELX's EBT over 4 years: stood at $2.5 billion in 2021, then rose by 5.65% to $2.6 billion in 2022, then crashed by 100.0% to $7052.8 in 2024, then increased by 5.52% to $7442.3 in 2025.
- Business Quant data shows EBT for RELX at $7442.3 in Q4 2025, $7052.8 in Q4 2024, and $2.6 billion in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 7,442.28 |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 318.00 Mn |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 632.50 Mn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 441.05 Mn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 129.00 Mn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | -224.50 Mn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 173.20 Mn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 137.51 Mn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 78.00 Mn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 119.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,442.28 |
| Dec 31, 2024 | 7,052.84 |
| Dec 31, 2022 | 2.62 Bn |
| Dec 31, 2021 | 2.48 Bn |